Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3192

Actual shortage: 254 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2927 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

14 (5%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NAPROXEN 500MG TABLET Resolved 2025-07-18 2025-08-08 263101
TEVA-NAPROXEN 375MG TABLET Resolved 2025-09-11 2025-10-30 266976
TEVA-NAPROXEN 500MG TABLET Actual shortage 2025-09-25 2025-11-20 267856
TEVA-NAPROXEN 500MG TABLET Resolved 2025-11-06 2025-11-13 271205
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2021-10-14 2022-02-17 147219
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-12-02 2022-02-10 150403
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176779
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176794
TEVA-NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-09 190740
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-06-08 2023-06-21 194094
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-07-04 2023-07-14 197052
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-10-05 2023-12-14 206392
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2024-01-11 2024-03-18 215719
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2025-05-30 2025-12-11 259011
TEVA-NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Actual shortage 2025-09-25 2025-12-11 267868
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Actual shortage 2025-09-25 2025-12-11 267871
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2021-10-21 2021-11-05 147708
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2024-11-08 2025-01-09 242341

Showing 2101 to 2120 of 3192

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65298
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Discontinued 2024-11-05 2024-11-05 242101
AERMONY RESPICLICK 113MCG POWDER (METERED DOSE) Discontinued 2025-05-28 2025-05-28 258571
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Discontinued 2025-09-02 2025-09-02 266350
ALERTEC 100MG TABLET Discontinued 2025-05-28 2025-05-28 258777
ALLERNIX 25MG TABLET Discontinued 2025-05-28 2025-05-28 258595
ALLERNIX EXTRA STRENGTH 50MG TABLET Discontinued 2025-05-28 2025-05-28 258562
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258705
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258771
BALMINIL DM (3MG/ML SUCROSE FREE) 15MG SYRUP Discontinued 2025-05-28 2025-05-28 258741
BALMINIL EXPECTORANT (SUCROSE FREE) 100MG SYRUP Discontinued 2025-05-28 2025-05-28 258750
BORTEZOMIB FOR INJECTION 3.5MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256094
CALMYLIN ACE 10MG 7.5MG 100MG SYRUP Discontinued 2024-06-28 2024-06-29 231574
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Discontinued 2019-08-08 2019-08-08 91175
CEFAZOLIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2023-11-27 2023-11-27 211558
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088

Showing 61 to 80 of 435